Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301 Proprietary Forzet formulation provides pharmacists, physicians and patients...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301 Proprietary Forzet formulation provides pharmacists, physicians and patients...

A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers at the Rudolf Virchow...

Type 1 diabetes is a serious disease that affects how the body controls sugar in the blood. People with this condition cannot produce enough insulin,...

Type 1 diabetes is a serious disease that affects how the body controls sugar in the blood. People with this condition cannot produce enough insulin,...

Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until...

Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until...

TUESDAY, March 10, 2026 -- Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA)...

THURSDAY, March 12, 2026 -- Less than 25 percent of adults with overweight or obesity without diabetes remain on any glucagon-like peptide-1 receptor...